| Filed On | Filing |
|---|---|
| 22 Oct 2026 |
8-K: Changes in Registrant's Certifying Accountant
We have read Item 4.01 of Form 8-K dated October 16, 2026 of Shuttle Pharmaceuticals Inc. and are in agreement with the statements contained therein with respect to our firm. We have no basis to agree or disagree with other statements of... |
| 24 Sep 2026 | 8-K/A: Financial Statements and Exhibits |
| 24 Sep 2026 | 10-Q |
| 16 Sep 2026 |
8-K: Unregistered Sales of Equity Securities
As previously disclosed, on September 9, 2026, Shuttle Pharmaceuticals Holdings, Inc. (the “Company”) held a Special Meeting of Stockholders (the “Meeting”) pursuant to which, among other things, the stockholders of the Company approved ... |
| 11 Sep 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On September 9, 2026, Shuttle Pharmaceuticals Holdings, Inc. (the “Company”) held a Special Meeting of Stockholders (the “Meeting”). |
| 02 Sep 2026 | DEFA14A |
| 02 Sep 2026 | 8-K: Other Events |
| 01 Sep 2026 | 8-K: Entry into a Material Definitive Agreement |
| 28 Aug 2026 | 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Regulation FD Disclosure |
| 17 Aug 2026 | NT 10-Q |
| 17 Aug 2026 | 8-K/A: Completion of Acquisition or Disposition of Assets |
| 13 Aug 2026 | DEFA14A |
| 13 Aug 2026 | Proxy statement: special meeting on September 3, 2026 |
| 03 Aug 2026 | PRE 14A |
| 15 Jul 2026 |
Form 4: Hrt Financial Lp, 10% owner
Sold 1,033 shares ($4.82K) · Sold 82,116 shares ($368K) |
| 13 Jul 2026 |
Form 4: Hrt Financial Lp, 10% owner
Bought 8,266 shares ($27.9K) · Bought 731 shares ($2.27K) |
| 13 Jul 2026 |
Form 3: Hrt Financial Lp, 10% owner
Holds 60,540 shares of Common Stock |
| 09 Jul 2026 |
Form 4: Hrt Financial Lp, 10% owner
Sold 10,580 shares ($35.2K) · Sold 18,531 shares ($65.2K) |
| 07 Jul 2026 |
Form 4: Hrt Financial Lp, 10% owner
Bought 7,851 shares ($27.8K) · Sold 9,022 shares ($31.7K) |
| 02 Jul 2026 |
Form 4: Hrt Financial Lp, 10% owner
Bought 3,959 shares ($13.1K) |
Loading...